Op Ed | Washington’s Healthcare Debate Must Consider Caregivers Too

Op Ed | Washington’s Healthcare Debate Must Consider Caregivers Too

In sponsorship with PhRMA for National Family Caregivers Month

One in four American adults is a family caregiver. For too many of them, navigating America’s complicated healthcare system is a constant struggle.

Can I get my mom an appointment when she needs one? Can I get my son’s prescription filled? Will insurance cover the treatment the doctor prescribed? If insurance says no, who do I call — and how many hours will it take to straighten out?

Nearly one in four family caregivers provides at least 40 hours of care a week. Half say caregiving has hurt their finances, while almost a quarter have taken on debt. Twenty percent can’t pay for necessities like groceries.

Caregivers’ burdens ultimately ripple through the economy in the form of lost wages, burnout, workforce departures, and lost productivity.

Yet healthcare policy often overlooks caregivers, risking greater burdens on families and making it harder for loved ones to get the timely care they need. As lawmakers consider healthcare policy reforms, they should account for the time and labor our healthcare system demands from families — and support changes that lower costs and reduce administrative burdens while preserving access to care.

The insurance system is an important place to start. Some members of Congress are already considering changes to burdensome insurance practices that can prevent caregivers from obtaining timely treatment for their loved ones.

Take prior authorization. Before an insurer will cover certain treatments or services, it often requires patients and doctors to get approval first.

In practice, that can mean hours on the phone with an insurance company, chasing down doctors or pharmacies, gathering paperwork, or fighting a denial — all before a loved one can get care their doctor has already prescribed.

Patients who are sick, elderly, or disabled may not be able to navigate that process on their own. Family caregivers often have to take over. One study found that more than 80% of caregivers whose loved ones encountered prior authorization ended up handling the process themselves.

That extra administrative work adds to an already significant strain on caregivers. Seven in 10 are employed. Nearly one in five has cut back their regular work hours because of caregiving, and 9% have quit working altogether.

Every hour a working caregiver spends fighting an insurer comes at the expense of something else — work, time with children, or meaningful time with the person they are caring for. Reforming practices such as prior authorization could help restore important time for caregivers and their families.

Lawmakers should also consider how prescription drug policy affects caregivers. Members of both parties have rightfully made lowering out-of-pocket costs a priority, and some have proposed expanding price controls by tying Medicare and Medicaid drug prices to drug prices in other countries.

But price controls also carry risks for patients. Other countries secure lower prices by restricting which medicines their health systems will cover, often using calculations that undervalue medicines for people with disabilities or chronic diseases. Patients in other countries often lack access to the most innovative medicines for this very reason.

Price controls could also reduce incentives to invest in new medicines, potentially preventing the development of better treatments that could help patients and ease the burden on caregivers.

Instead of expanding drug price controls, Congress could better help patients and their families by reforming pharmacy benefit managers, or PBMs, the middlemen who negotiate rebates and discounts from drug manufacturers and decide which medicines insurance plans cover.

PBMs are supposed to help lower patient costs, but they often fail to pass the savings they negotiate on to patients. They also have an incentive to steer patients toward costlier drugs. That’s because their compensation is based on the discounts they negotiate, which are often larger for drugs with higher list prices.

Congress can change those incentives to keep PBMs from steering patients toward pricier medicines and ensure that negotiated savings directly benefit patients.

Caring for an aging parent, a spouse with cancer, or a child with a disability will always demand time and sacrifice.

During National Family Caregivers Month, policymakers can support caregivers in a meaningful way by pursuing reforms that lower costs, preserve access to care, and reduce administrative work.

Those reforms would give caregivers more time to care for the people they love, earn a living, and live fuller lives. That would strengthen families, workplaces, and the economy they sustain.

In sponsorship with PhRMA for National Family Caregivers Month.

PhRMA represents the nation’s leading biopharmaceutical research companies. Our success in developing and delivering medicines to help patients live longer and healthier lives depends on ethical relationships and behavior.